Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 4, Number 1—March 1998

Zoonotic Tuberculosis due to Mycobacterium bovis in Developing Countries

O. Cosivi*, J.M. Grange, C.J. Daborn, M.C. Raviglione*, T. Fujikura, D. Cousins, R.A. Robinson, H.F.A.K. Huchzermeyer, I. de Kantor, and F.-X. Meslin*
Author affiliations: *World Health Organization, Geneva, Switzerland; †Imperial College School of Medicine, National Heart and Lung Institute, London, United Kingdom; ‡Edinburgh University, Edinburgh, Scotland; ¶The University of Zambia, Lusaka, Zambia; §Department of Agriculture, South Perth, Australia; **College of Veterinary Medicine, Veterinary Teaching Hospital, St. Paul, Minnesota, USA; ††Onderstepoort Veterinary Institute, Onderstepoort, South Africa; and ‡‡Pan American Health Organization/ World Health Organization, Buenos Aires, Argentina

Main Article

Figure 7

Cow milk production by region (43).

Figure 7. Cow milk production by region (43).

Main Article

  1. Acha  PN, Szyfres  B. Zoonotic tuberculosis. In: Zoonoses and communicable diseases common to man and animals. 2nd edition. Washington: Pan American Health Organization/World Health Organization; 1987: Scientific Publication No. 503.
  2. Collins  CH, Grange  JM. A review. The bovine tubercle bacillus. J Appl Bacteriol. 1983;55:1329.PubMedGoogle Scholar
  3. Cosivi  O, Meslin  F-X, Daborn  CJ, Grange  JM. The epidemiology of Mycobacterium bovis infection in animals and humans, with particular reference to Africa. Scientific and Technical Review. 1995;14:73346.PubMedGoogle Scholar
  4. Raviglione  MC, Snider  DE, Kochi  A. Global epidemiology of tuberculosis. JAMA. 1995;273:2206. DOIPubMedGoogle Scholar
  5. Houde  C, Dery  P. Mycobacterium bovis sepsis in an infant with human immunodeficiency virus infection. Pediatr Infect Dis J. 1988;7:8102.PubMedGoogle Scholar
  6. Cornuz  J, Fitting  JW, Beer  V, Chave  JP. Mycobacterium bovis and AIDS. AIDS. 1991;5:10389. DOIPubMedGoogle Scholar
  7. Dupon  M, Ragnaud  JM. Tuberculosis in patients infected with human immunodeficiency virus 1. A retrospective multicentre study of 123 cases in France. Quarterly Journal of Medicine [New Series 85] 1992;306:719-30.
  8. Yates  MD, Pozniak  A, Grange  JM. Isolation of mycobacteria from patients seropositive for the human immunodeficiency virus (HIV) in south east England: 198492. Thorax. 1993;48:9905. DOIPubMedGoogle Scholar
  9. Dankner  WM, Waecker  NJ, Essey  MA, Moser  K, Thompson  M, Davis  CH. Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine (Baltimore). 1993;72:1137. DOIPubMedGoogle Scholar
  10. Bouvet  E, Casalino  E, Mendoza-Sassi  G, Lariven  S, Vallee  E, Pernet  M, A nosocomial outbreak of multidrug-resistant Mycobacterium bovis among HIV-infected patients. A case-control study. AIDS. 1993;7:145360. DOIPubMedGoogle Scholar
  11. Boletín Epidemiológico Semanal. Vigilancia de la tuberculosis zoonótica por M. bovis: sistema de enfermedades de declaración obligatoria 1982-1995. Red Nacional de Vigilancia Epidemiológica de España. Centro Nacional de Epidemiología. 1995;3:1834.
  12. Grange  JM, Daborn  C, Cosivi  O. HIV-related tuberculosis due to Mycobacterium bovis. Eur Respir J. 1994;7:15646. DOIPubMedGoogle Scholar
  13. Moda  G, Daborn  CJ, Grange  JM, Cosivi  O. The zoonotic importance of Mycobacterium bovis. Tuber Lung Dis. 1996;77:1038. DOIPubMedGoogle Scholar
  14. Daborn  CJ, Grange  JM, Kazwala  RR. The bovine tuberculosis cyclean African perspective. [Symposium Supplement]. J Appl Bacteriol. 1997;81:27s32s.
  15. World Health Organization. Report of the WHO meeting on animal tuberculosis; 1992 Apr 27; Cairo, Egypt. Geneva: The Organization; 1992. Unpub. document WHO/CDS/VPH/92.112.
  16. World Health Organization. Report of the WHO meeting on zoonotic tuberculosis (Mycobacterium bovis), with the participation of the FAO; 1993 Nov 15. Geneva, Switzerland. Geneva: The Organization; 1993. Unpub. document WHO/CDS/VPH/93.130.
  17. World Health Organization. Report of WHO Working Group on zoonotic tuberculosis (Mycobacterium bovis), with the participation of FAO; 1994 June 14. Mainz, Germany. Geneva: The Organization; 1994. Unpub. document WHO/CDS/VPH/94.137.
  18. World Health Organization/Pan American Health Organization. VIII Inter-American meeting, at the ministerial level on animal health; 1993 Apr 27-29. Washington, DC. Washington: The Organizations; 1993. Document RIMSA 8/26.
  19. Dolin  PJ, Raviglione  MC, Kochi  A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ. 1994;72:21320.PubMedGoogle Scholar
  20. Thoen  CO, Steele  JH, eds. Regional and Country Status Reports. Part 2. Mycobacterium bovis infection in animals and humans. Ames (IA): Iowa State University Press; 1995. p. 167-345.
  21. Food and Agriculture Organization. In: Welte WR, editor. FAO/OIE/WHO Animal Health Yearbook 1993. Washington: The Organization; 1994. FAO Animal Production and Health Series No. 33.
  22. de Kantor  IN, Ritacco  V. Bovine tuberculosis in Latin America and the Caribbean: current status, control and eradication programs. Vet Microbiol. 1994;40:514. DOIPubMedGoogle Scholar
  23. Grange  JM, Yates  MD. Zoonotic aspects of Mycobacterium bovis infection. Vet Microbiol. 1994;40:13751. DOIPubMedGoogle Scholar
  24. Gervois  M, Vaillant  JM, Fontaine  JF, Laroche  G, Dubois  G. Epidemiologie de l'infection humaine par Mycobacterium bovis. Arch Monaldi. 1972;27:294317.PubMedGoogle Scholar
  25. Cousins  DV, Williams  SN. A study of Mycobacterium bovis infection in Australian patients 1970-1994. In: Griffit F, de Lisle G, editors. Tuberculosis in wildlife and domestic animals. Otago, New Zealand: University of Otago Press: 1995. p. 260-3.
  26. Krebs  A, Käppler  W. Die Bedeutung von Mycobacterium bovis in der Tuberkuloseepidemiologie. Zeitschift für Erkrankungen der Atmungs Organe. 1982;158:1019.
  27. Cormican  MG, Flynn  J. Tuberculosis in the West of Ireland 1986-1990. Ir J Med Sci. 1992;161:702. DOIPubMedGoogle Scholar
  28. Collins  C, Kelly  P, Bryne  C, Denham  F, Clancy  L. Is bovine, atypical or resistant tuberculosis a problem? Ir Med J. 1987;80:667.PubMedGoogle Scholar
  29. Brett  JL, Humble  MW. Incidence of human tuberculosis caused by Mycobacterium bovis. N Z Med J. 1991;104:134.PubMedGoogle Scholar
  30. Sauret  J, Jolis  R, Ausina  V, Castro  E, Cornudella  R. Human tuberculosis due to Mycobacterium bovis: report of 10 cases. Tuber Lung Dis. 1992;73:38891. DOIPubMedGoogle Scholar
  31. La tuberculose en Suisse en 1994. Bern, Switzerland: Bulletin 37, Office fédéral de la santé publique;1994. p.10-1.
  32. Karlson  AG, Carr  DT. Tuberculosis caused by Mycobacterium bovis. Report of six cases: 1954-1968. Ann Intern Med. 1970;73:97983.PubMedGoogle Scholar
  33. Elsabban  MS, Lofty  O, Awad  WM, Soufi  HS, Mikhail  DG, Hammam  HM, Bovine tuberculosis and its extent of spread as a source of infection to man and animals in Arab Republic of Egypt. In: Proceedings of the International Union Against Tuberculosis and Lung Disease Conference on Animal Tuberculosis in Africa and the Middle East; 1992 Apr 28-30; Cairo, Egypt. Paris: The Union; 1992. p.198-211.
  34. Nafeh  MA, Medhat  A, Abdul-Hameed  A-G, Ahmad  YA, Rashwan  NM, Strickland  GT. Tuberculous peritonitis in Egypt: the value of laparoscopy in diagnosis. Am J Trop Med Hyg. 1992;47:4707.PubMedGoogle Scholar
  35. Idigbe  EO, Anyiwo  CE, Onwujekwe  DI. Human pulmonary infections with bovine and atypical mycobacteria in Lagos, Nigeria. J Trop Med Hyg. 1986;89:1438.PubMedGoogle Scholar
  36. Idrisu  A, Schnurrenberger  P. Public health significance of bovine tuberculosis in four northern states of Nigeria: a mycobacteriologic study. Niger Med J. 1977;7:3847.
  37. Mposhy  M, Binemo-Madi  C, Mudakikwa  B. Incidence de la tuberculose bovine sur la santé des populations du Nord-Kivu (Zaïre). Rev Elev Med Vet Pays Trop. 1983;36:158.PubMedGoogle Scholar
  38. Cook  AJC, Tuchili  LM, Buve  A, Foster  SD, Godfrey-Faussett  P, Pandey  GS, Human and bovine tuberculosis in the Monze district of Zambiaa cross-sectional study. Br Vet J. 1996;152:3746. DOIPubMedGoogle Scholar
  39. Barrera  L, de Kantor  IN. Nontuberculous mycobacteria and Mycobacterium bovis as a cause of human disease in Argentina. Trop Geogr Med. 1987;39:2227.PubMedGoogle Scholar
  40. Sequeira de Latini  MD, Latini  OA, Lopez  ML, Cecconi  JO. Tuberculosis bovina en seres humanos. 2a. parte: Periodo 1977-1989. Revista Argentina del Torax. 1990;51:131.
  41. Lall  JM. Tuberculosis among animals in India. Vet Bull. 1969;39:38590.
  42. O'Reilly  LM, Daborn  CJ. The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tuber Lung Dis. 1995;76(Suppl 1):146. DOIPubMedGoogle Scholar
  43. Food and Agriculture Organization. Production. Vol. 47. Rome: Food and Agriculture Organization of the United Nations; 1993. FAO Statistic Series No. 117.
  44. Walshe  MJ, Grindle  J, Nell  A, Bachmann  M. Dairy development in sub-Saharian Africa. Washington DC: World Bank, 1991. African Technical Department Series; World Bank Technical Paper No. 135.
  45. National Research Council. Livestock disease eradicationevaluation of the cooperative State-Federal Bovine Tuberculosis Eradication Program. Washington: National Academy Press; 1994.
  46. Blancou  J, Cheneau  Y. Influence de la tuberculose sur le gain de poids de zébus à l'engrais. Rev Elev Med Vet Pays Trop. 1974;27:7580.PubMedGoogle Scholar
  47. World Health Organization. Third Report of the Joint FAO/WHO Expert Committee on Zoonoses. Geneva: The Organization; 1967. Technical Report Series No. 378.
  48. Maggi  C, Alvarez  E, de Kantor  I, Nader  A. Methodology for estimating the losses caused by bovine tuberculosis in Argentina. Scientific and Technical Review. 1998. In press.
  49. Barwinek  F, Taylor  NM. Assessment of the socio-economic importance of bovine tuberculosis in Turkey and possible strategies for control or eradication. Bakanliklar, Ankara, Turkey: Turkish-German Animal Health Information Project, General Directorate of Protection and Control; 1996.
  50. Grange  JM, Yates  MD, de Kantor  I. Guidelines for speciation within the Mycobacterium tuberculosis complex. 2nd ed. Geneva: World Health Organization; 1996. Unpub. document WHO/EMC/ZOO/96.4.
  51. Malin  AS, Young  DB. Designing a vaccine for tuberculosis. Unraveling the tuberculosis genomecan we build a better BCG? BMJ. 1996;312:1495.PubMedGoogle Scholar
  52. Griffin  JFT, Mackintosh  CG, Buchan  GS. Animal models of protective immunity in tuberculosis to evaluate candidate vaccines. Trends Microbiol. 1995;3:41824. DOIPubMedGoogle Scholar
  53. Doucet-Populaire  F, Lalande  V, Carpentier  E, Bourgoin  A, Dailloux  M, Bollet  A, A blind study of the polymerase chain reaction for the detection of Mycobacterium tuberculosis DNA. Tuber Lung Dis. 1996;77:35862. DOIPubMedGoogle Scholar
  54. van Embden  JDA, Schouls  LM, van Soolingen  D. Molecular techniques: application in epidemiologic studies. In: Thoen CO, Steele JH, editors. Mycobacterium bovis infection in animals and humans. Ames (IA): Iowa State University Press; 1995. p. 15-27.
  55. Liebana  E, Aranaz  A, Francis  B, Cousins  D. Assessment of genetic markers for species differentiation within the Mycobacterium tuberculosis complex. J Clin Microbiol. 1996;34:9338.PubMedGoogle Scholar
  56. World Health Organization. Expert Committee on Tuberculosis report on the Fifth Session; 1950 Sep 11-16; Geneva, Switzerland. Geneva: The Organization; 1951. Technical Report Series 32.
  57. World Health Organization. Report of a WHO/FAO/OIE consultation on animal tuberculosis vaccines; 1994 Aug 3-5; Geneva, Switzerland. Geneva: The Organization; 1994. Unpub. document WHO/CDS/VPH/94.138.

Main Article

Page created: December 13, 2010
Page updated: December 13, 2010
Page reviewed: December 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.